LFB Biotechnologies S.A.S.U.

10% owner at rEVO Biologics, Inc. · on record since Dec 22, 2006
Director at rEVO Biologics, Inc. · on record since Nov 4, 2009
10% owner at TG THERAPEUTICS, INC. · on record since Dec 7, 2012

Insider trading activity of LFB Biotechnologies S.A.S.U.

Transactions on record: 27; since Jan 5, 2007

Open-market buys: 4; $10.6M

Open-market sells: 0

Companies traded: 2; last filing May 11, 2015

Figures computed from official regulatory filings — .

Companies where LFB Biotechnologies S.A.S.U. has traded

TG THERAPEUTICS, INC.3 tx · $750K · May 11, 2015
rEVO Biologics, Inc.24 tx · $86.4M · Jun 17, 2010

Track record of LFB Biotechnologies S.A.S.U.

Statistical track record

Free account

Open-market buys: 9

Last buy: Feb 17, 2015

Win rates, median returns and the proven-insider analysis come with a free account.

Create a free account

Transaction history of LFB Biotechnologies S.A.S.U.

Co-insiders of LFB Biotechnologies S.A.S.U.

ABEL DOUGLASTG THERAPEUTICS, INC.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
TG THERAPEUTICS, INC.Listing on record	May 11, 2015	Other	2,500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TG THERAPEUTICS, INC.Listing on record	May 11, 2015	OtherD (derivative)	-2,500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TG THERAPEUTICS, INC.Listing on record	May 11, 2015	Buy	114,855	6.53 USD	$750K	conv 27First in 12mo	SEC
rEVO Biologics, Inc.Listing unverified	Jun 17, 2010	BuyD (derivative)	0	7,000,000.00	n/a (Converted to USD in the nightly refresh)		SEC
rEVO Biologics, Inc.Listing unverified	Jan 8, 2010	OtherD (derivative)	-6,750	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
rEVO Biologics, Inc.Listing unverified	Jan 8, 2010	OtherD (derivative)	-6,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
rEVO Biologics, Inc.Listing unverified	Jan 8, 2010	Other	3,017,703	2.24	$6.8M		SEC
rEVO Biologics, Inc.Listing unverified	Jan 8, 2010	Other	2,281,368	2.63	$6M		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	Buy	3,387,851	1.07	$3.6M	conv 22	SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	OtherD (derivative)	-13,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	AwardD (derivative)	6,750	—	n/a (No price was disclosed in the filing)		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	Other	4,562,737	2.63	$12M		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	OtherD (derivative)	-12,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	ExerciseD (derivative)	6,000	1,000.00	$6M		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	ExerciseD (derivative)	6,750	1,000.00	$6.8M		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	AwardD (derivative)	6,000	—	n/a (No price was disclosed in the filing)		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	Other	6,035,407	2.24	$13.5M		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	ExerciseD (derivative)	-6,750	—	n/a (No price was disclosed in the filing)		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	BuyD (derivative)	12,000	1,000.00	$12M		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	ExerciseD (derivative)	-6,000	—	n/a (No price was disclosed in the filing)		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	BuyD (derivative)	13,500	1,000.00	$13.5M		SEC
rEVO Biologics, Inc.Listing unverified	Dec 31, 2008	BuyD (derivative)	48,387,096	—	n/a (No price was disclosed in the filing)	Cluster	SEC
rEVO Biologics, Inc.Listing unverified	Dec 31, 2008	BuyD (derivative)	23,193,548	—	n/a (No price was disclosed in the filing)	Cluster	SEC
rEVO Biologics, Inc.Listing unverified	Mar 27, 2008	Other	14,500,000	—	n/a (No price was disclosed in the filing)		SEC
rEVO Biologics, Inc.Listing unverified	Mar 27, 2008	OtherD (derivative)	-14,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
TG THERAPEUTICS, INC.Listing on record	May 11, 2015	Other	2,500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TG THERAPEUTICS, INC.Listing on record	May 11, 2015	OtherD (derivative)	-2,500,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
TG THERAPEUTICS, INC.Listing on record	May 11, 2015	Buy	114,855	6.53 USD	$750K	conv 27First in 12mo	SEC
rEVO Biologics, Inc.Listing unverified	Jun 17, 2010	BuyD (derivative)	0	7,000,000.00	n/a (Converted to USD in the nightly refresh)		SEC
rEVO Biologics, Inc.Listing unverified	Jan 8, 2010	OtherD (derivative)	-6,750	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
rEVO Biologics, Inc.Listing unverified	Jan 8, 2010	OtherD (derivative)	-6,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
rEVO Biologics, Inc.Listing unverified	Jan 8, 2010	Other	3,017,703	2.24	$6.8M		SEC
rEVO Biologics, Inc.Listing unverified	Jan 8, 2010	Other	2,281,368	2.63	$6M		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	Buy	3,387,851	1.07	$3.6M	conv 22	SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	OtherD (derivative)	-13,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	AwardD (derivative)	6,750	—	n/a (No price was disclosed in the filing)		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	Other	4,562,737	2.63	$12M		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	OtherD (derivative)	-12,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	ExerciseD (derivative)	6,000	1,000.00	$6M		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	ExerciseD (derivative)	6,750	1,000.00	$6.8M		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	AwardD (derivative)	6,000	—	n/a (No price was disclosed in the filing)		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	Other	6,035,407	2.24	$13.5M		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	ExerciseD (derivative)	-6,750	—	n/a (No price was disclosed in the filing)		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	BuyD (derivative)	12,000	1,000.00	$12M		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	ExerciseD (derivative)	-6,000	—	n/a (No price was disclosed in the filing)		SEC
rEVO Biologics, Inc.Listing unverified	Nov 4, 2009	BuyD (derivative)	13,500	1,000.00	$13.5M		SEC
rEVO Biologics, Inc.Listing unverified	Dec 31, 2008	BuyD (derivative)	48,387,096	—	n/a (No price was disclosed in the filing)	Cluster	SEC
rEVO Biologics, Inc.Listing unverified	Dec 31, 2008	BuyD (derivative)	23,193,548	—	n/a (No price was disclosed in the filing)	Cluster	SEC
rEVO Biologics, Inc.Listing unverified	Mar 27, 2008	Other	14,500,000	—	n/a (No price was disclosed in the filing)		SEC
rEVO Biologics, Inc.Listing unverified	Mar 27, 2008	OtherD (derivative)	-14,500	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC